Drug of Abuse Testing Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

CHAPTER 1. Industry Overview of Drug of Abuse Testing Market

1.1. Definition and Scope

1.1.1. Definition of Drug of Abuse Testing

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Drug of Abuse Testing Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Drug of Abuse Testing Market By Drug Type

1.2.3. Drug of Abuse Testing Market By Product

1.2.4. Drug of Abuse Testing Market By Sample Type

1.2.5. Drug of Abuse Testing Market By End User

1.2.6. Drug of Abuse Testing Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Sample Type

2.2.1. Secondary Source

2.2.2. Primary Source

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Drug of Abuse Testing Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Drug of Abuse Testing Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Price Trend of Key Raw Materials

3.8.1. Raw Material Suppliers

3.8.2. Proportion of Manufacturing Cost Structure

3.8.2.1. Raw Material

3.8.2.2. Labor Cost

3.8.2.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2022

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022

4.2. R&D Status of Major Manufacturers in 2022

CHAPTER 5. Drug of Abuse Testing Market By Drug Type

5.1. Introduction

5.2. Drug of Abuse Testing Revenue By Drug Type

5.2.1. Drug of Abuse Testing Revenue (USD Billion) and Forecast, By Drug Type, 2020-2032

5.2.2. Alcohol

5.2.2.1. Alcohol Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3. LSD

5.2.3.1. LSD Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.4. Cocaine

5.2.4.1. Cocaine Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.5. Opioids

5.2.5.1. Opioids Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.6. Marijuana/Cannabis

5.2.6.1. Marijuana/Cannabis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.7. Others

5.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 6. Drug of Abuse Testing Market By Product

6.1. Introduction

6.2. Drug of Abuse Testing Revenue By Product

6.2.1. Drug of Abuse Testing Revenue (USD Billion) and Forecast, By Product, 2020-2032

6.2.2. Equipment

6.2.2.1. Equipment Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.2.2. Immunoassay Analyzers

6.2.2.2.1. Immunoassay Analyzers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.2.3. Breath Analyzers

6.2.2.3.1. Breath Analyzers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.2.4. Chromatography Instruments

6.2.2.4.1. Chromatography Instruments Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3. Consumables

6.2.3.1. Consumables Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3.2. Reagents

6.2.3.2.1. Reagents Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3.3. Rapid Test Kits

6.2.3.3.1. Rapid Test Kits Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3.4. Others

6.2.3.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 7. Drug of Abuse Testing Market By Sample Type

7.1. Introduction

7.2. Drug of Abuse Testing Revenue By Sample Type

7.2.1. Drug of Abuse Testing Revenue (USD Billion) and Forecast, By Sample Type, 2020-2032

7.2.2. Urine

7.2.2.1. Urine Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.3. Breath

7.2.3.1. Breath Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.4. Saliva

7.2.4.1. Saliva Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.5. Blood

7.2.5.1. Blood Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.6. Hair

7.2.6.1. Hair Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.7. Others

7.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 8. Drug of Abuse Testing Market By End User

8.1. Introduction

8.2. Drug of Abuse Testing Revenue By End User

8.2.1. Drug of Abuse Testing Revenue (USD Billion) and Forecast, By End User, 2020-2032

8.2.2. Hospitals

8.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.3. Workplaces

8.2.3.1. Workplaces Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.4. Research Labs

8.2.4.1. Research Labs Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.5. Criminal Justice Systems

8.2.5.1. Criminal Justice Systems Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 9. North America Drug of Abuse Testing Market By Country 

9.1. North America Drug of Abuse Testing Market Overview

9.2. U.S.

9.2.1. U.S. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032

9.2.2. U.S. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032

9.2.3. U.S. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

9.2.4. U.S. Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032

9.3. Canada

9.3.1. Canada Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032

9.3.2. Canada Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032

9.3.3. Canada Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

9.3.4. Canada Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032

9.4. North America PEST Analysis

CHAPTER 10. Europe Drug of Abuse Testing Market By Country

10.1. Europe Drug of Abuse Testing Market Overview

10.2. U.K.

10.2.1. U.K. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032

10.2.2. U.K. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032

10.2.3. U.K. Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

10.2.4. U.K. Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032

10.3. Germany

10.3.1. Germany Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032

10.3.2. Germany Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032

10.3.3. Germany Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

10.3.4. Germany Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032

10.4. France

10.4.1. France Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032

10.4.2. France Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032

10.4.3. France Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

10.4.4. France Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032

10.5. Spain

10.5.1. Spain Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032

10.5.2. Spain Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032

10.5.3. Spain Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

10.5.4. Spain Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032

10.6. Rest of Europe

10.6.1. Rest of Europe Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032

10.6.2. Rest of Europe Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032

10.6.3. Rest of Europe Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

10.6.4. Rest of Europe Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032

10.7. Europe PEST Analysis

CHAPTER 11. Asia Pacific Drug of Abuse Testing Market By Country

11.1. Asia Pacific Drug of Abuse Testing Market Overview

11.2. China

11.2.1. China Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032

11.2.2. China Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032

11.2.3. China Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

11.2.4. China Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032

11.3. Japan

11.3.1. Japan Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032

11.3.2. Japan Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032

11.3.3. Japan Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

11.3.4. Japan Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032

11.4. India

11.4.1. India Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032

11.4.2. India Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032

11.4.3. India Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

11.4.4. India Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032

11.5. Australia

11.5.1. Australia Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032

11.5.2. Australia Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032

11.5.3. Australia Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

11.5.4. Australia Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032

11.6. South Korea

11.6.1. South Korea Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032

11.6.2. South Korea Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032

11.6.3. South Korea Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

11.6.4. South Korea Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032

11.7. Rest of Asia-Pacific

11.7.1. Rest of Asia-Pacific Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032

11.7.2. Rest of Asia-Pacific Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032

11.7.3. Rest of Asia-Pacific Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

11.7.4. Rest of Asia-Pacific Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032

11.8. Asia Pacific PEST Analysis

CHAPTER 12. Latin America Drug of Abuse Testing Market By Country

12.1. Latin America Drug of Abuse Testing Market Overview

12.2. Brazil

12.2.1. Brazil Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032

12.2.2. Brazil Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032

12.2.3. Brazil Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

12.2.4. Brazil Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032

12.3. Mexico

12.3.1. Mexico Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032

12.3.2. Mexico Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032

12.3.3. Mexico Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

12.3.4. Mexico Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032

12.4. Rest of Latin America

12.4.1. Rest of Latin America Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032

12.4.2. Rest of Latin America Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032

12.4.3. Rest of Latin America Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

12.4.4. Rest of Latin America Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032

12.5. Latin America PEST Analysis

CHAPTER 13. Middle East & Africa Drug of Abuse Testing Market By Country 

13.1. Middle East & Africa Drug of Abuse Testing Market Overview

13.2. GCC

13.2.1. GCC Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032

13.2.2. GCC Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032

13.2.3. GCC Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

13.2.4. GCC Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032

13.3. South Africa

13.3.1. South Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032

13.3.2. South Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032

13.3.3. South Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

13.3.4. South Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032

13.4. Rest of Middle East & Africa

13.4.1. Rest of Middle East & Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Drug Type, 2020-2032

13.4.2. Rest of Middle East & Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Product, 2020-2032

13.4.3. Rest of Middle East & Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By Sample Type, 2020-2032

13.4.4. Rest of Middle East & Africa Drug of Abuse Testing Revenue (USD Billion) and Forecast By End User, 2020-2032

13.5. Middle East & Africa PEST Analysis

CHAPTER 14. Player Analysis Of Drug of Abuse Testing Market

14.1. Drug of Abuse Testing Market Company Share Analysis

14.2. Competition Matrix

14.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment

14.2.2. New Product Launches and Product Enhancements

14.2.3. Mergers And Acquisition In Global Drug of Abuse Testing Market

14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 15. Company Profile

15.1. Abbott Laboratories

15.1.1. Company Snapshot

15.1.2. Business Overview

15.1.3. Financial Overview

15.1.3.1. Revenue (USD Billion), 2022

15.1.3.2. Abbott Laboratories 2022 Drug of Abuse Testing Business Regional Distribution

15.1.4. Product /Service and Specification

15.1.5. Recent Developments & Business Strategy

15.2. Danaher Corporation

15.3. Cordant Health Solutions

15.4. LabCorp

15.5. Legacy Medical Services

15.6. Quest Diagnostics, Inc.

15.7. LGC Group

15.8. DrugScan

15.9. Mayo Clinic Laboratories

15.10. Precision Diagnostics